Evidence map›Paper›PMID 41533728›Full record

ArticlePLoS computational biology2026

Powerful large scale inference in high dimensional mediation analysis.

Asmita Roy, Xianyang Zhang

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Asmita RoyDepartment of Biostatistics/Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0003-2270-2866
Xianyang ZhangDepartment of Statistics, Texas A&M University, College Station, Texas, United States of America.

Funding

Methods for microbiome compositional dataR01GM144351 · NIGMS · MAYO CLINIC ROCHESTER · PI Jun Chen, Xianyang Zhang · 2022 to 2026
$1.6M
NIGMS NIH HHS R01 GM144351
6 · The paper itself

Abstract

In genome-wide epigenetic studies, determining how exposures (e.g., Single Nucleotide Polymorphisms) affect outcomes (e.g., gene expression) through intermediate variables, such as DNA methylation, is a key challenge. Mediation analysis provides a framework to identify these causal pathways; however, testing for mediation effects involves a complex composite null hypothesis. Existing methods, such as Sobel's test or the Max-P test, are often underpowered in this context because they rely on null distributions determined under only a subset of the null space and are not optimized for the multiple testing burden inherent in high-dimensional data. To address these limitations, we introduce MLFDR (Mediation Analysis using Local False Discovery Rates), a novel method for high-dimensional mediation analysis. MLFDR leverages local false discovery rates, calculated from the coefficients of structural equation models, to construct an optimal rejection region. We demonstrate theoretically and through simulation that MLFDR asymptotically controls the false discovery rate and achieves superior statistical power compared to recent high-dimensional mediation methods. In real data applications, MLFDR identified 20%-50% more significant mediators than existing methods, demonstrating its ability to uncover biological signals missed by conventional approaches.

Indexed as

Computational BiologyMediation AnalysisAlgorithmsComputer SimulationDNA MethylationEpigenesis, GeneticGenome-Wide Association StudyHumansModels, StatisticalPolymorphism, Single Nucleotide

Identifiers

PMID41533728
PMCPMC12829953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.